相关实验视频
Updated: Jan 13, 2026
20:16
Detecting Anastasis In Vivo by CaspaseTracker Biosensor
Published on: February 1, 2018
9.7K
精确度之外:儿童和AYA癌症中的环境生存率
Juan Antonio Ortega-García1,2, Omar Shakeel3, Nicole M Wood4
1Pediatric Environmental Health Specialty Unit, Department of Pediatrics, Hospital Clínico Universitario Virgen de la Arrixaca (HCUVA), 30120 Murcia, Spain.
Cancers
|January 10, 2026
概括
儿童癌症生存模式正在从反应性,治疗后的监测转变为主动的,从诊断开始的环境护理. 这种新方法结合了环境和社会因素,改善了儿童癌症幸存者的长期健康结果.
科学领域:
- 儿科瘤学 儿科瘤学
- 幸存者护理 幸存者护理
- 环境健康 环境健康
- 曝光学 (Exposomics) 是一种表现学.
背景情况:
- 目前的儿科癌症生存模型是反应性的,专注于治疗后查,忽视了健康的关键环境和社会决定因素.
- 这种传统的方法不足以利用癌症诊断的关键窗口,在整个生命过程中进行主动的健康干预.
研究的目的:
- 审查国际框架和关于癌症生存环境决定因素,暴露学和毒基因学的证据.
- 描述儿科环境历史 (PEHis) 到环境健康指南针 (AHC) 的演变,以实现综合,主动的幸存者护理.
- 提出一个转向环境的范式转变,从癌症诊断开始的暴露意识护理.
主要方法:
- 对国际生存指南 (COG,IGHG,PanCare,NCCN) 的叙述性审查.
- 综合环境决定因素,曝光学,毒基因组学和实施策略的证据.
- 描述了儿科环境史 (PEHis) 和环境健康指南针 (AHC) 在日常护理中的发展和整合.
主要成果:
- 儿科环境史 (PEHis) 将基于指导方针的护理进行操作,增强生存,健康行为和护理协调.
- 环境健康指南针 (AHC) 扩展了PEHis,包括动态风险评估,生物监测和毒基因组解释,用于从诊断到预期决策.
- 该研究概述了范式的转变,扩展了指导方针,临床工具和用于实施和评估下一代幸存者计划的指标.
结论:
- 儿童癌症幸存者护理必须从晚期监测过渡到在诊断时开始的积极主动,环境,暴露意识的护理.
- 整合暴露学,突变流行病学和分析可以减少不良事件,促进公平,并将瘤学与行星健康保持一致.
- PEHis-AHC连续性为未来的幸存者计划提供了一个可扩展的模型,通过暴露性和社会上下文数据扩展精准医学.
相关概念视频
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
01:29Life Histories
22.5K
Overview
22.5K
01:15Assumptions of Survival Analysis
391
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
391
01:20The Retinoblastoma Gene
4.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.7K
02:41Lethal Alleles
17.7K
Agouti: A Lethal Allele
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
Lucien Cuénot discovered lethal alleles in 1905 while studying the inheritance of coat color in mice. The agouti gene is responsible for the color of the coat in mice. This gene codes for an agouti-signaling protein, which is responsible for melanin distribution in mammals. The wild-type allele gives rise to gray-brown coat color in mice, while the mutant allele gives rise to yellow coat color. In addition to coat color, the agouti gene is associated with the yellow...
17.7K
01:20Actuarial Approach
284
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
284